Nucleic Acids Research,
Journal Year:
2024,
Volume and Issue:
52(14), P. 8595 - 8608
Published: June 29, 2024
Abstract
The
CRISPR-Cas
system
provides
a
versatile
RNA-guided
approach
for
broad
range
of
applications.
Thanks
to
advances
in
RNA
synthetic
biology,
the
engineering
guide
RNAs
(gRNAs)
has
enabled
conditional
control
system.
However,
achieving
precise
regulation
efficient
modulation
internal
metabolic
processes
remains
challenging.
In
this
work,
we
developed
robust
dCas9
regulator
with
engineered
gRNAs
enable
tight
endogenous
genes.
Our
Escherichia
coli
can
gene
expression
upon
specific
interaction
trigger
dynamic
as
high
130-fold,
evaluating
up
three-input
logic
A
OR
(B
AND
C).
gRNA-mediated
targeting
genes,
lacZ,
malT
and
poxB,
caused
differential
growth
via
flux
control.
Further,
could
regulate
essential
cytoskeleton
ftsZ
mreB,
cell
filamentation
division.
Finally,
three
types
two-input
gates
be
applied
regulation,
resulting
morphological
changes.
successful
operation
application
based
on
programmable
interactions
suggests
that
our
compatible
other
Cas-effectors
implemented
host
organisms.
Cancer Biology & Therapy,
Journal Year:
2023,
Volume and Issue:
24(1)
Published: July 27, 2023
Recent
evidence
has
shown
that
the
human
microbiome
is
associated
with
various
diseases,
including
cancer.
The
salivary
microbiome,
fecal
and
circulating
microbial
DNA
in
blood
plasma
have
all
been
used
experimentally
as
diagnostic
biomarkers
for
many
types
of
microbiomes
present
within
local
tissue,
other
regions,
tumors
themselves
to
promote
restrict
development
progression
cancer,
most
often
by
affecting
cancer
cells
or
host
immune
system.
These
microbes
also
impact
efficacy
therapies,
radiation,
chemotherapy,
immunotherapy.
Here,
we
review
research
advances
focused
on
how
these
different
facets
why
they
are
important
clinical
care
It
only
better
understanding
roles
play
diagnosis,
development,
progression,
treatment
will
be
able
catch
treat
early.
Journal of Bacteriology,
Journal Year:
2023,
Volume and Issue:
205(7)
Published: June 29, 2023
Techniques
by
which
to
genetically
manipulate
members
of
the
microbiota
enable
both
evaluation
host-microbe
interactions
and
an
avenue
monitor
modulate
human
physiology.
Genetic
engineering
applications
have
traditionally
focused
on
model
gut
residents,
such
as
Escherichia
coli
lactic
acid
bacteria.
However,
emerging
efforts
develop
synthetic
biology
toolsets
for
"nonmodel"
resident
microbes
could
provide
improved
foundation
microbiome
engineering.
As
genome
tools
come
online,
so
too
novel
engineered
microbes.
Engineered
bacteria
facilitate
investigations
roles
their
metabolites
host
health
allow
potential
live
microbial
biotherapeutics.
Due
rapid
pace
discovery
in
this
burgeoning
field,
minireview
highlights
advancements
genetic
all
Journal of Nanobiotechnology,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Oct. 26, 2024
Nanobodies
(Nbs)
are
antibody
fragments
derived
from
heavy-chain-only
IgG
antibodies
found
in
the
Camelidae
family
as
well
cartilaginous
fish.
Their
unique
structural
and
functional
properties,
such
their
small
size,
ability
to
be
engineered
for
high
antigen-binding
affinity,
stability
under
extreme
conditions,
ease
of
production,
have
made
them
promising
tools
diagnostics
therapeutics.
This
potential
was
realized
2018
with
approval
caplacizumab,
world's
first
Nb-based
drug.
Currently,
Nbs
being
investigated
clinical
trials
a
broad
range
treatments,
including
targeted
therapies
against
PDL1
Epidermal
Growth
Factor
Receptor
(EGFR),
cardiovascular
diseases,
inflammatory
neurodegenerative
disorders
Alzheimer's
disease,
Parkinson's
amyotrophic
lateral
sclerosis.
They
also
studied
detecting
imaging
autoimmune
conditions
infectious
diseases
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2).
A
variety
methods
now
available
generate
target-specific
quickly
efficiently
at
low
costs,
increasing
accessibility.
article
examines
these
diverse
applications
roles.
Only
most
recent
articles
published
last
five
years
been
used
summarize
advanced
developments
field.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(5), P. 2056 - 2056
Published: Feb. 26, 2025
Cancer
vaccines,
aimed
at
evolving
the
human
immune
system
to
eliminate
tumor
cells,
have
long
been
explored
as
a
method
of
cancer
treatment
with
significant
clinical
potential.
Traditional
delivery
systems
face
challenges
in
directly
targeting
cells
and
delivering
adequate
amounts
antigen
due
hostile
microenvironment.
Emerging
evidence
suggests
that
certain
bacteria
naturally
home
on
tumors
modulate
antitumor
immunity,
making
bacterial
vectors
promising
vehicle
for
precision
vaccines.
Live
vehicles
offer
several
advantages,
including
colonization,
precise
drug
delivery,
stimulation,
them
compelling
option
immunotherapy.
In
this
review,
we
explore
mechanisms
action
behind
living
bacteria-based
recent
progress
popular
chassis,
strategies
specific
payload
biocontainment
ensure
safety.
These
approaches
will
lay
foundation
developing
an
affordable,
widely
applicable
vaccine
system.
This
review
also
discusses
future
opportunities
harnessing
bacterial-based
vaccines
enhanced
therapeutic
outcomes
treatment.
Chemical Society Reviews,
Journal Year:
2024,
Volume and Issue:
53(16), P. 8306 - 8378
Published: Jan. 1, 2024
As
natural
living
substances,
microorganisms
have
emerged
as
useful
resources
in
medicine
for
creating
microbe-material
hybrids
ranging
from
nano
to
macro
dimensions.
The
engineering
of
microbe-involved
nanomedicine
capitalizes
on
the
distinctive
physiological
attributes
microbes,
particularly
their
intrinsic
"living"
properties
such
hypoxia
tendency
and
oxygen
production
capabilities.
Exploiting
these
remarkable
characteristics
combination
with
other
functional
materials
or
molecules
enables
synergistic
enhancements
that
hold
tremendous
promise
improved
drug
delivery,
site-specific
therapy,
enhanced
monitoring
treatment
outcomes,
presenting
substantial
opportunities
amplifying
efficacy
disease
treatments.
This
comprehensive
review
outlines
microbial
derivatives
used
biomedicine
specific
advantages
therapeutic
application.
In
addition,
we
delineate
fundamental
strategies
mechanisms
employed
constructing
hybrids.
diverse
biomedical
applications
constructed
hybrids,
encompassing
bioimaging,
anti-tumor,
anti-bacteria,
anti-inflammation
diseases
therapy
are
exhaustively
illustrated.
We
also
discuss
current
challenges
prospects
associated
clinical
translation
hybrid
platforms.
Therefore,
unique
versatility
potential
exhibited
by
position
them
promising
candidates
development
next-generation
biomaterials
theranostic
functionalities.
Life
Science
can
divide
into
many
branches.
In
each
branch,
scope
of
research
is
enormous.
The
future
the
technology
driven
which
help
to
solve
problems
in
daily
life.
book
entitled
“Trends
and
Technology
Development
Sciences”
provides
knowledge
on
some
recent
trends
keep
us
updated
same.
It
enhances
diagnosis;
treatment
diseases
artificial
intelligence
perform
more
complex
tasks.
India
one
fastest
growing
markets
industry.
pandemic
made
this
field
think
innovative
way
take
up
challenges
such
as
vaccine
production.
Manufacturing
pharmaceuticals,
biotechnology-based
food
medicines,
medical
devices,
biomedical
technologies,
nutraceuticals,
environmental
science,
cloud
technology,
etc.
are
important
fields
development
happening
all
these
branches.Collaboration
vital
between
academia
industry
funding
crucial
for
development.
Recent
boost
good
services,
simplify
processes
cost
cutting.
Moreover,
learning
surrounding
interest
detect
solution
most
glitches.
Advancement
essential
country
population.
Study
merits
demerits
equally
sustainable
science.
book,
techniques
different
included.